Effects of 19 herbal extracts on the sensitivity to paclitaxel or 5-fluorouracil in HeLa cells

Biological and Pharmaceutical Bulletin

Volumn 28, Issue 1, 2005, Pages 138-142

  Takara, Kohji ^a   Horibe, Sayo ^a   Obata, Yukihisa ^a   Yoshikawa, Eri ^a   Ohnishi, Noriaki ^a   Yokoyama, Teruyoshi ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

HeLa cell; Herb; MDR1 P glycoprotein; Multidrug resistance; Traditional herbal medicine

Indexed keywords

ARTEMISIA CAPILLARIS EXTRACT; ASIASARUM SIEBOLDI EXTRACT; COPTIS RHIZOME; EPHEDRA SINICA EXTRACT; FLUOROURACIL; GARDENIA JASMINOIDES EXTRACT; GINGER EXTRACT; GINSENG EXTRACT; GLYCOPROTEIN P; GLYCYRRHIZA URALENSIS EXTRACT; HERBACEOUS AGENT; MULTIDRUG RESISTANCE PROTEIN 1; PACLITAXEL; PAEONIA RADIX; PINELLIA TERNATA EXTRACT; PLANT EXTRACT; PLATYCODON GRANDIFLORUM EXTRACT; PORIA COCOS EXTRACT; REHMANNIA GLUTINOSA EXTRACT; RHODAMINE 123; RHUBARB EXTRACT; SCUTELLARIA BAICALENSIS EXTRACT; SOPHORA FLAVESCENS EXTRACT; UNCLASSIFIED DRUG; ZANTHOXYLUM PIPERITUM EXTRACT; ZIZYPHUS JUJUBA EXTRACT; PLANT MEDICINAL PRODUCT;

ARTICLE; ASIASARUM SIEBOLDI; CANCER COMBINATION CHEMOTHERAPY; COLORIMETRY; CONTROLLED STUDY; DRUG CYTOTOXICITY; DRUG EFFECT; DRUG SENSITIVITY; DRUG TRANSPORT; HELA CELL; HERBAL MEDICINE; HUMAN; HUMAN CELL; JUJUBE; MEDICINAL PLANT; MULTIDRUG RESISTANCE; PINELLIA; PLATYCODON; ZANTHOXYLUM; COMPARATIVE STUDY; DOSE RESPONSE; DRUG POTENTIATION; ISOLATION AND PURIFICATION;

DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG SYNERGISM; FLUOROURACIL; HELA CELLS; HUMANS; PACLITAXEL; PLANT EXTRACTS; PLANT PREPARATIONS;

EID: 18444406248     PISSN: 09186158     EISSN: None     Source Type: Journal    
DOI: 10.1248/bpb.28.138     Document Type: Article

References (20)

1. Pal S. K., Shukla Y., Asian Pac. J. Cancer Prev., 4, 281-288 (2003).
2. Ernst E., Int. J. Clin. Pharmacol. Ther., 42, 157-159 (2004).
3. Shukla Y., Pal S. K., Asian Pac. J. Cancer Prev., 5, 3-14 (2004).
4. Tsuruo T., Naito M., Tomida A., Fujita N., Mashima T., Sakamoto H., Haga N., Cancer Sci., 94, 15-21 (2003).
5. Takara K., Sakaeda T., Okumura K., Anticancer Drugs, 15, 303-309 (2004).
6. Fojo T., Bates S., Oncogene, 22, 7512-7523 (2003).
7. Tsuruo T., Intern. Med., 42, 237-243 (2003).
8. Takara K., Sakaeda T., Yagami T., Kobayashi H., Ohmoto N., Horinouchi M., Nishiguchi K., Okumura K., Biol. Pharm. Bull., 25, 771-778 (2002).
9. Iida N., Takara K., Ohmoto N., Nakamura T., Kimura T., Wada A., Hirai M., Sakaeda T., Okumura K., Biol. Pharm. Bull., 24, 1032-1036 (2001).
10. Takara K., Tsujimoto M., Ohnishi N., Yokoyama T., J. Pharm. Pharmacol., 55, 675-681 (2003).
11. Takara K., Tsujimoto M., Kokufu M., Ohnishi N., Yokoyama T., Biol. Pharm. Bull., 26, 205-209 (2003).
12. Lowry O. H., Nira J., Rosebrough A., Farr L., Randall R. J., J. Biol. Chem., 193, 265-275 (1951).
13. Xu J. Y., Zhou Q., Shen P., Tang W., J. Exp. Clin. Cancer Res., 18, 549-552 (1999).
14. Efferth T., Davey M., Olbrich A., Rucker G., Gebhart E., Davey R., Blood Cells Mol. Dis., 28, 160-168 (2002).
15. Sadava D., Ahn J., Zhan M., Pang M. L., Ding J., Kane S. E., Cancer Chemother. Pharmacol., 49, 261-266 (2002).
16. Chang J. Y., Chang C. Y., Kuo C. C., Chen L. T., Wein Y. S., Kuo Y. H., Mol. Pharmacol., 65, 77-84 (2004).
17. Choi C. H., Kang G., Min Y. D., Planta Med., 69, 235-240 (2003).
18. Kemper E. M., van Zandbergen A. E., Cleypool C., Mos H. A., Boogerd W., Beijnen J. H., van Tellingen O., Clin. Cancer Res., 9, 2849-2855 (2003).
19. Kemper E. M., Cleypool C., Boogerd W., Beijnen J. H., van Tellingen O., Cancer Chemother. Pharmacol., 53, 173-178 (2004).
20. van Zuylen L., Sparreboom A., van der Gaast A., Nooter K., Eskens F. A., Brouwer E., Bol C. J., de Vries R., Palmer P. A., Verweij J., Eur. J. Cancer., 38, 1090-1099 (2002).